Science & Technology
Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R44AG063589-02
Award Ceiling
$1.7M
Award Floor
$1.7M
Close Date
May 31, 2027
442 days leftTotal Funding
$1.7M
Expected Awards
1
Posted Date
Sep 20, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-2R44AG063589-02
Description
SBIR Phase Phase II award: "Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease" awarded to TYMORA ANALYTICAL OPERATIONS LLC in WEST LAFAYETTE, Indiana. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,669,130. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.